BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8012061)

  • 1. Evidence for a relationship between intracellular GTP levels and the induction of HL-60 leukemia cell differentiation by 5,10-dideazatetrahydrofolic acid (DDATHF).
    Sokoloski JA; Pizzorno G; Beardsley GP; Sartorelli AC
    Oncol Res; 1993; 5(8):293-9. PubMed ID: 8012061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of HL-60 leukemia cell differentiation by the novel antifolate 5,10-dideazatetrahydrofolic acid.
    Sokoloski JA; Beardsley GP; Sartorelli AC
    Cancer Res; 1989 Sep; 49(17):4824-8. PubMed ID: 2758415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of HL-60 leukemia cell differentiation by tetrahydrofolate inhibitors of de novo purine nucleotide biosynthesis.
    Sokoloski JA; Beardsley GP; Sartorelli AC
    Cancer Chemother Pharmacol; 1991; 28(1):39-44. PubMed ID: 2040032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (6R)-5,10-Dideaza-5,6,7,8-tetrahydrofolic acid effects on nucleotide metabolism in CCRF-CEM human T-lymphoblast leukemia cells.
    Pizzorno G; Moroson BA; Cashmore AR; Beardsley GP
    Cancer Res; 1991 May; 51(9):2291-5. PubMed ID: 1707749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the induction of the differentiation of HL-60 leukemia cells by antifolates.
    Sokoloski JA; Beardsley GP; Sartorelli AC
    Cancer Commun; 1989; 1(3):199-207. PubMed ID: 2700913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular metabolism of 5,10-dideazatetrahydrofolic acid in human leukemia cell lines.
    Pizzorno G; Sokoloski JA; Cashmore AR; Moroson BA; Cross AD; Beardsley GP
    Mol Pharmacol; 1991 Jan; 39(1):85-9. PubMed ID: 1702876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decrease in the intracellular guanosine 5'-triphosphate concentration is necessary for granulocytic differentiation of HL-60 cells, but growth cessation and differentiation are not associated with a change in the activation state of Ras, the transforming principle of HL-60 cells.
    Pilz RB; Huvar I; Scheele JS; Van den Berghe G; Boss GR
    Cell Growth Differ; 1997 Jan; 8(1):53-9. PubMed ID: 8993834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis.
    Beardsley GP; Moroson BA; Taylor EC; Moran RG
    J Biol Chem; 1989 Jan; 264(1):328-33. PubMed ID: 2909524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells.
    Smith SG; Lehman NL; Moran RG
    Cancer Res; 1993 Dec; 53(23):5697-706. PubMed ID: 8242626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
    Lucas DL; Webster HK; Wright DG
    J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of guanine ribonucleotide accumulation on the metabolism and cell cycle of human lymphoid cells.
    Sidi Y; Hudson JL; Mitchell BS
    Cancer Res; 1985 Oct; 45(10):4940-5. PubMed ID: 2411392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5,10-Dideazatetrahydrofolic acid reduces toxicity and deoxyadenosine triphosphate pool, expansion in cultured L1210 cells treated with inhibitors of thymidylate synthase.
    Chong LK; Tattersall MH
    Biochem Pharmacol; 1995 Mar; 49(6):819-27. PubMed ID: 7702640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antineoplastic activity of 5-fluorouracil in mice bearing colon 38 tumor by (6R)5,10-dideazatetrahydrofolic acid.
    Pizzorno G; Davis SJ; Hartigan DJ; Russello O
    Biochem Pharmacol; 1994 Jun; 47(11):1981-8. PubMed ID: 7516657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
    Zhao R; Gao F; Babani S; Goldman ID
    Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
    Cheng HW; Armstrong RD; Sadée W
    Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
    Niitsu N; Ishii Y; Matsuda A; Honma Y
    Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the synthesis of glycoproteins and induction of the differentiation of HL-60 promyelocytic leukemia cells by 6-methylmercaptopurine ribonucleoside.
    Sokoloski JA; Sartorelli AC
    Cancer Res; 1987 Dec; 47(23):6283-7. PubMed ID: 3479242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects and kill of human T-cell leukemia by 5-deazaacyclotetrahydrofolate, a specific inhibitor of glycineamide ribonucleotide transformylase.
    Smith GK; Duch DS; Dev IK; Kaufmann SH
    Cancer Res; 1992 Sep; 52(18):4895-903. PubMed ID: 1516046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium.
    Danilenko M; Wang Q; Wang X; Levy J; Sharoni Y; Studzinski GP
    Cancer Res; 2003 Mar; 63(6):1325-32. PubMed ID: 12649194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid.
    Erba E; Sen S; Sessa C; Vikhanskaya FL; D'Incalci M
    Br J Cancer; 1994 Feb; 69(2):205-11. PubMed ID: 8297715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.